Top 20 reports

1. SensiumVitals® vital signs monitoring patch - Sep  2014

2. RAPIDEC® CARBA NP test for confirmation or detection of Carbapenemase producing bacteria - May  2014

3. Sheffield Support Snood for neurodegenerative conditions - Feb  2014

4. LiverMultiScan™ multiparametric MRI for liver disease - Oct  2014

5. Daclatasvir and sofosbuvir (Sovaldi) with and without ribavirin for chronic hepatitis C infection - Apr  2014

6. LipiView® and LipiFlow® for dry eye management - Jun  2014

7. New and emerging technologies for inherited retinal diseases - Jul  2014

8. Dinutuximab (Unituxin) for high risk neuroblastoma – maintenance therapy - Jun  2014

9. OkuStim® System for the treatment of retinitis pigmentosa - Sep  2014

10. LCZ696 for chronic heart failure – first line - Aug  2013

11. Cologuard® for colorectal cancer screening - Jul  2014

12. SpaceOAR® perirectal spacing system for prostate cancer radiation - Dec  2014

13. Ibrutinib for relapsed or refractory mantle cell lymphoma - Oct  2013

14. Pertuzumab (Perjeta) for HER2-positive locally advanced, inflammatory or early breast cancer – neo-adjuvant in combination with trastuzumab and docetaxel - Feb  2014

15. Nellix® EndoVascular Aneurysm Sealing System for abdominal aortic aneurysm repair - Jul  2014

16. Curelator Headache™ digital platform for adults with migraine - Aug  2014

17. OPTIMIZER™ system for chronic heart failure - Oct  2014

18. Strokefinder MD100 microwave tomography for early diagnosis of stroke type - Mar  2014

19. Sofosbuvir with ledipasvir for hepatitis C, genotype 1 - Aug  2013

20. Lumacaftor and ivacaftor combination therapy for cystic fibrosis – first line - Feb  2014

Pause Ticker Next Item Previous Item

What’s new on the site

View all outputs

Latest news articles


Latest Medtech Alerts

The following Medtech Alerts on innovative new and emerging medical devices and diagnostics have recently been uploaded to our website: Ma...

NICE update topic selection guidance on biosimilars

The National Institute for Health and Care Excellence (NICE) has updated its position on the selection of biosimilar products for appraisa...

Updated EuroScan Methods Toolkit Published

The EuroScan International Network has recently launched an updated version of its methods toolkit for the identification and assessment o...

Latest pharmacological technology briefings now available

Our latest batch of briefings on pharmacological technologies in development is now available. These include briefings in the following sp...

Latest briefings on pharmacological technologies for the treatment of cancer

Our latest batch of briefings on pharmacological technologies in development for the treatment of cancer is now available. These include: ...

View all articles

Join Our Mailing list

Our regular newsletter contains a quick roundup of the latest news, briefings and reports on Horizon Scanning

Follow us on Twitter

Newer agents for hepatitis C mean decision taken to discontinue boceprevir and telaprevir in the USA #hepC

Jan 27, 2015, 8:33 am